ATF4 and Parkinson disease: A recent study in mouse mesencephalic and cortical neuronal cultures has demonstrated that treatment with PD-relevant neurotoxins, MPP + and 6-OHDA, as well as α-synuclein aggregation results in the sustained expression of ATF4 in the nucleus of dopaminergic neurons [169].